Clinical Trial

Neoadjuvant Treatment of Breast Cancer

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 23, 2021 (before its estimated March 2023 completion). Its status may not reflect the trial's current state.
Summary
Observational investigation of participants who are given neoadjuvant treatment for invasive breast cancer. The scope of the study is to collect information on standardized treatment results, to explore the causes of dose modification and its effect on efficacy, to explore potential prognostic factors, and to explore the long-term side effects of different treatment modalities.
Trial Details
NCT Number NCT05131893
Lead Sponsor National Institute of Oncology, Hungary
Conditions Breast Cancer
Enrollment 300 participants
Start Date 2022-03
Primary Completion 2023-03 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2021-11-23